CHENGDU, China, 9. August 2024 /PRNewswire/ — WestGene Biopharma ist stolz darauf, bekannt zu geben, dass sein therapeutischer mRNA-Krebsimpfstoff WGc-043 eine doppelte IND-Zulassung von Chinas National Medical Products Administration (NMPA) und der US FDA erhalten hat. Dies ist der…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.